Cargando…

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24

Members of the Ebolavirus genus demonstrate a marked differences in pathogenicity in humans with Ebola (EBOV) being the most pathogenic, Bundibugyo (BDBV) less pathogenic, and Reston (RESTV) is not known to cause a disease in humans. The VP24 protein encoded by members of the Ebolavirus genus blocks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramanathan, Palaniappan, Tigabu, Bersabeh, Santos, Rodrigo I., Ilinykh, Philipp A., Kuzmina, Natalia, Vogel, Olivia A., Thakur, Naveen, Ahmed, Hamza, Wu, Chao, Amarasinghe, Gaya K., Basler, Christopher F., Bukreyev, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222226/ https://www.ncbi.nlm.nih.gov/pubmed/37243162 http://dx.doi.org/10.3390/v15051075

Ejemplares similares

Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin
por: Santos, Rodrigo I., et al.
Publicado: (2023)

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
por: Ilinykh, Philipp A., et al.
Publicado: (2018)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Structure of the Reston ebolavirus VP30 C-terminal domain
por: Clifton, Matthew C., et al.
Publicado: (2014)

Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
por: Murin, Charles D., et al.
Publicado: (2021)

Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis
por: Xu, Wei, et al.
Publicado: (2017)

Effects of Overexpression of the Egyptian Fruit Bat Innate Immune Genes on Filovirus Infections in the Host Cells
por: Kuzmin, Ivan V., et al.
Publicado: (2021)

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
por: King, Liam B., et al.
Publicado: (2019)

Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion
por: Luthra, Priya, et al.
Publicado: (2017)

Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody
por: West, Brandyn R., et al.
Publicado: (2019)

Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants
por: Shu, Qingbo, et al.
Publicado: (2021)

Ebola Virus NP Binding to Host Protein Phosphatase-1 Regulates Capsid Formation
por: Ahmad, Asrar, et al.
Publicado: (2023)

Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene
por: Edwards, Megan R., et al.
Publicado: (2022)

Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
por: Gilchuk, Pavlo, et al.
Publicado: (2020)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
por: Harrison, Angela R., et al.
Publicado: (2021)

Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis
por: Fang, Jingru, et al.
Publicado: (2018)

Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment
por: Landeras-Bueno, Sara, et al.
Publicado: (2019)

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35
por: Zinzula, Luca, et al.
Publicado: (2012)

Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region
por: Schoeder, Clara T., et al.
Publicado: (2022)

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2016)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
por: Bale, Shridhar, et al.
Publicado: (2012)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2018)

Infectious pancreatic necrosis virus proteins VP2, VP3, VP4 and VP5 antagonize IFNa1 promoter activation while VP1 induces IFNa1
por: Lauksund, Silje, et al.
Publicado: (2015)

Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebolaviruses
por: Wrensch, Florian, et al.
Publicado: (2015)

Treatment with Ad5-Porcine Interferon-α Attenuates Ebolavirus Disease in Pigs
por: Senthilkumaran, Chandrika, et al.
Publicado: (2022)

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
por: Chen, Elaine C., et al.
Publicado: (2023)

P300-mediated NEDD4 acetylation drives ebolavirus VP40 egress by enhancing NEDD4 ligase activity
por: Zhang, Linliang, et al.
Publicado: (2021)

Cysteine Mutations in the Ebolavirus Matrix Protein VP40 Promote Phosphatidylserine Binding by Increasing the Flexibility of a Lipid-Binding Loop
por: Johnson, Kristen A., et al.
Publicado: (2021)

Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly
por: van Tol, Sarah, et al.
Publicado: (2022)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Ebolavirus comparative genomics
por: Jun, Se-Ran, et al.
Publicado: (2015)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2
por: Ilinykh, Philipp A., et al.
Publicado: (2022)

Chicken infectious anemia virus (CIAV) VP1 antagonizes type I interferon (IFN-I) production by inhibiting TBK1 phosphorylation
por: Chen, Juncheng, et al.
Publicado: (2023)

Silencing the alarms: Innate immune antagonism by rotavirus NSP1 and VP3
por: Morelli, Marco, et al.
Publicado: (2015)

Ebolavirus Evolution: Past and Present
por: de La Vega, Marc-Antoine, et al.
Publicado: (2015)

Virological diagnosis of Ebolavirus infection
por: Smith, D. W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gqpjbf39o20p19jpboufbbsgk0